Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Insulin Resistance × DLBS3233 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2 Insulin Resistance 1

Interventions

Metformin 5 lime 1 cinnulin PF 1 World Health Organization oral rehydration solution 1 Resistance Training 1 Pioglitazone 1 Liraglutide 1 Exercise 1 Diet Therapy 1 DLBS3233 1 Contraceptives, Oral 1 Clomiphene 1 Cholecalciferol 1 Caloric Restriction 1 Biguanides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01999686 2019-05-28

POSITIF

Dexa Medica Group

Phase 3 Completed

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡